Skip to main content
ConductScienceScienceDex

Maus, Marcela Valderrama

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #1,511
Unclaimed recordClaim profile
  • Rising Star
  • R01 Holder
  • Top 10% Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$3.3M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#1,511
By linked amount among FY2023 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Maus, Marcela Valderrama. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Maus, Marcela Valderrama as a PI. Multi-PI records show the full award amount for context.

  • 1UG3CA283619-01UG3Contact PI
    CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
    Massachusetts General Hospital
    $1.4M
    award amount
  • 5R01CA249062-03R01Contact PI
    Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
    Massachusetts General Hospital
    $689.1K
    award amount
  • 5R01CA252940-04R01Contact PI
    Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel
    Massachusetts General Hospital
    $683.3K
    award amount
  • 5R01CA238268-05R01Contact PI
    Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
    Massachusetts General Hospital
    $545.2K
    award amount

Award organization

Organizations that administered FY2023 awards listing Maus, Marcela Valderrama as a PI.

FY2023 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2012
    First NIH Award
    Massachusetts General Hospital
  2. 2015
    $500K Cumulative Funding
  3. 2015
    R01 Grant Holder
  4. 2019
    $1M Cumulative Funding
  5. 2021
    $2M Cumulative Funding
  6. 2021
    Entered Top 50% Nationally
    Ranked #3537
  7. 2021
    Entered Top 25% Nationally
    Ranked #3537
  8. 2022
    $5M Cumulative Funding
  9. 2023
    Entered Top 10% Nationally
    Ranked #1511

Explore further

Find collaborators for Maus, Marcela Valderrama

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →